Search results
Showing 2491 to 2505 of 8973 results
In development Reference number: GID-HST10067 Expected publication date: 19 August 2026
In development Reference number: GID-IPG10441 Expected publication date: 17 December 2026
Tarlatamab for maintenance treatment of extensive-stage small-cell lung cancer [ID6749]
Awaiting development Reference number: GID-TA11977 Expected publication date: TBC
In development Reference number: GID-TA10575 Expected publication date: TBC
Awaiting development Reference number: GID-TA11758 Expected publication date: TBC
Zilucoplan for treating antibody positive generalised myasthenia gravis [ID4008]
In development Reference number: GID-TA11096 Expected publication date: TBC
Rozanolixizumab for treating antibody-positive generalised myasthenia gravis [ID5092]
In development Reference number: GID-TA10994 Expected publication date: TBC
In development Reference number: GID-TA11023 Expected publication date: TBC
STG320 for treating allergic rhinitis or rhinoconjunctivitis caused by house dust mites [ID1278]
Awaiting development Reference number: GID-TA10279 Expected publication date: TBC
Sodium zirconium cyclosilicate for treating hyperkalaemia (partial review of TA599) [ID6439]
In development Reference number: GID-TA11561 Expected publication date: TBC
Pembrolizumab with chemoradiotherapy for untreated unresectable oesophageal cancer [ID6270]
Awaiting development Reference number: GID-TA11303 Expected publication date: TBC
In development Reference number: GID-TA11140 Expected publication date: TBC
Awaiting development Reference number: GID-TA10972 Expected publication date: TBC
In development Reference number: GID-IPG10392 Expected publication date: TBC
In development Reference number: GID-TA11440 Expected publication date: TBC